This content was created by Everyday Health Media on behalf of an advertiser.
More Information.
Content on this page was created by the Everyday Health Media team and is funded by an advertiser. The content conforms to Everyday Health Media’s editorial standards for accuracy, objectivity, and balance. The advertiser may select the specialty area but does not edit or approve the content.
Invasive Pneumococcal Disease Prevention in Adults
Invasive Pneumococcal Disease: Which Workplace Exposures Raise the Risk?
That was the question asked by Swedish investigators who examined the effect of occupational exposures—including their nature and work location—on the risk of transmission of invasive pneumococcal disease.
Do Adults Benefit When Kids Get Pneumococcal Conjugate Vaccines?
The answer appears to be "yes." A sharp decrease in rates of pneumococcal pneumonia caused by pneumococcal conjugate vaccine serotypes was observed in men and women, according to these recent findings from a Japanese study.
PCV13 Is Shifting Trends in Invasive Pneumococcal Disease
With data from patients in Olmstead County, Minnesota, researchers at Mayo Clinic recently took a close look at the efficacy of the 13-valent pneumococcal conjugate vaccine (PCV13). Here’s what they found.